drugset / Trial / NCT00508859

Maintenance Study for Adolescent Depression

NCT00508859

RandomizedParallel-groupDouble-blindTreatment

Summary

This study examined the benefit of continued treatment with an antidepressant medication, sertraline, in adolescents with depression who improved on sertraline acutely. We hypothesize that adolescents who remained on sertraline long term were less likely to have a recurrence of depression compared to those on placebo.

Timeline

Start
1997-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 25 mg
Subject Sertraline Small molecule 50 mg